Skip to content
Pharmacology & Mechanisms

GHRH

Growth hormone-releasing hormone, a 44-amino acid hypothalamic peptide that stimulates pulsatile GH secretion from the anterior pituitary. Sermorelin, CJC-1295, and tesamorelin are synthetic analogs of GHRH.

Frequently Asked Questions

What is GHRH?
Growth hormone-releasing hormone, a 44-amino acid hypothalamic peptide that stimulates pulsatile GH secretion from the anterior pituitary. Sermorelin, CJC-1295, and tesamorelin are synthetic analogs of GHRH.
Why is GHRH important in peptide research?
GHRH is a key pharmacological concept that determines how peptides interact with the body. Understanding this term helps practitioners optimize dosing protocols, predict therapeutic outcomes, and minimize side effects.

Related Terms

Growth hormone secretagogue

A compound that stimulates the pituitary gland to release growth hormone by activating the ghrelin receptor or GHRH receptor. Includes peptides (ipamorelin, GHRP-2, GHRP-6) and the oral compound MK-677.

IGF-1

Insulin-like growth factor 1, a hormone produced primarily by the liver in response to growth hormone. Mediates many of GH’s anabolic effects including muscle growth, bone density, and tissue repair.

Related Peptide Profiles

Sermorelin

A synthetic GHRH analog (first 29 amino acids of GHRH) used to stimulate natural growth hormone production. Previously FDA-approved for GH deficiency diagnosis.

CJC-1295

A synthetic growth hormone-releasing hormone (GHRH) analog that stimulates pulsatile GH secretion. Available with or without DAC (Drug Affinity Complex).

Tesamorelin

A synthetic GHRH analog FDA-approved (Egrifta) for HIV-associated lipodystrophy. Stimulates pulsatile growth hormone release.

← Back to full glossary